The Maryland Technology Development Corp. said Friday it approved $8.4 million in funding for stem cell research projects seeking treatment and cures for heart failure, stroke, multiple sclerosis, vascular diseases, Parkinson’s Disease, schizophrenia, autism spectrum disorders and cancer.
The money is going to the Maryland Stem Cell Research Commission, which is administered by TEDCO. The commission will dole the funds out to 26 entities and researchers working on projects.
The money comes from a fund established in 2006 by the General Assembly and governor's office to promote state-funded stem cell research. It is given through grants and loans to public and private researchers.
Since the fund was created, more than $120 million has been committed to 349 research projects. All of the projects must be conducted in Maryland and involve human stem cells.
This year awards include:
- $750,000 over three years to BioCardia, Inc. for heart failure trials;
- $4.6 million in grants to five reseachers from The Johns Hopkins School of Medicine and scientists from the Hugo W. Moser Research Institute at Kennedy Krieger and TheraCord LLC for projects that have preliminary data to support a hypothesis.
- $2.2 million in awards for exploratory projects with little or no preliminary data to seven researchers from The Johns Hopkins School of Medicine, two researchers from the University of Maryland Baltimore and one from the Moser Research Institute at Kennedy Krieger.
- $880,000 in post-doctoral fellowship awards to students from the University of Maryland Baltimore, Johns Hopkins University Homewood and The Johns Hopkins School of Medicine.